MIR4471

Across TCGA pan-cancer cohorts, MIR4471 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated MIR4471 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher MIR4471 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4471 expression acts as an unfavorable survival marker.

LUSC, UCEC, and BRCA are the cancer types where MIR4471 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	All	0.154	0.679	<.001	90	view →
UCEC	OS	Tertile	II,III,IV	0.204	0.768	.003	90	view →
BRCA	OS	Tertile	All	0.786	0.963	.006	72	view →
UVM	OS	Tertile	All	0.292	0.674	.035	18	view →
STAD	OS	Tertile	All	0.461	0.740	.014	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

MIR4471–LUSC (OS)

Open the LUSC breakdown →